Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Teva Gains Japanese Approval for Copaxone

September 30, 2015 7:55 am | News | Comments

The drug is intended for the prevention of relapse of multiple sclerosis. Read more...

HIV Patients Should be Included in Early Clinical Trials of Anti-TB Drugs

September 30, 2015 7:40 am | by European Lung Foundation | News | Comments

These findings were presented at European Respiratory Society’s International Congress 2015. Read more...


FDA Accepts Sanofi's NDA for Lixisenatide

September 30, 2015 7:30 am | News | Comments

The proprietary name for lixisenatide in the United States is under consideration. Read more...


Novel Oral Anticoagulants Require Improved Safety Data to Challenge Warfarin

September 30, 2015 7:20 am | by Lakshmi Dharmarajan, Ph.D, Senior Cardiovascular and Metabolic Disorders Analyst, GlobalData | News | Comments

Smaller observational studies and registry data should be exploited to obtain clinical evidence regarding the detrimental effects of lower doses of NOACs. Read more...


New Head-to-Head Stiolto Respimat Data Presented at ERS Annual Congress

September 29, 2015 12:32 pm | News | Comments

Boehringer Ingelheim Pharmaceuticals, Inc. today announced new data that show increase in FEV1 AUC0–12, which is a measure of lung function, with Stiolto Respimat compared to a European formulation of a combination of long-acting beta agonist (LABA), salmeterol, and inhaled corticosteroid (ICS), fluticasone propionate (50/500 µg, 50/250 µg). Read more...


Discovery Provides Insight into Life-Threatening Respiratory Distress in Newborns

September 29, 2015 12:21 pm | News | Comments

St. Jude Children's Research Hospital scientists have a lead on reducing life-threatening respiratory problems in infants born to women who develop the liver disorder intrahepatic cholestasis of pregnancy (ICP). The research appears today in the scientific journal Nature Communications. Read more...


Lilly's Cyramza Improves Progression-Free Survival in Bladder Cancer Trial

September 29, 2015 11:50 am | News | Comments

A Phase 2 study of Eli Lilly and Company's Cyramza (ramucirumab) in combination with docetaxel met its primary endpoint, demonstrating a statistically significant increase in progression-free survival (PFS) for patients with locally advanced or metastatic urothelial carcinoma who failed prior platinum-based therapy. Bladder cancer accounts for the vast majority of all urothelial carcinoma. Read more...


FDA Sends Warning to Startup Selling Suspicious Cancer Test

September 29, 2015 11:46 am | by Ryan Bushey, Associate Editor | News | Comments

The agency requested a meeting with the company's CEO to discuss the data the company claims supports the test’s efficacy, as well as their marketing materials. Read more...


Sanofi Settles Lawsuit Enabling Rival to Lantus Insulin

September 29, 2015 11:45 am | by Linda A. Johnson, AP Business Writer | News | Comments

 A less-expensive version of the world's top-selling insulin, Sanofi's Lantus, could go on sale in the U.S. late next year. Read more...


New Autism Genes Are Revealed in Largest-Ever Study

September 29, 2015 10:45 am | News | Comments

In the largest, most comprehensive genomic analysis of autism spectrum disorder (ASD) conducted to date, an international research team led by UC San Francisco scientists has identified 65 genes that play a role in the disorder, 28 of which are reported with "very high confidence," meaning that there is 99 percent certainty that these genes contribute to the risk of developing ASD. Read more...


Why Drugmakers are Interested in Iran

September 29, 2015 8:00 am | by Ryan Bushey, Associate Editor | News | Comments

Novo Nordisk and other pharmaceutical companies are cautiously exploring business opportunities in the country. Read more...


Bill Gates, UN say Malaria Could be Eradicated by 2040

September 29, 2015 7:45 am | by Maria Cheng, AP Medical Writer | News | Comments

The report calls for a doubling of the money spent on malaria by 2025 and new ways to control the mosquitoes that spread the disease. Read more...


Mylan Launches Generic Invega Tablets

September 29, 2015 7:35 am | News | Comments

Paliperidone Extended-Release Tablets 1.5 mg, 3 mg, 6 mg and 9 mg, had U.S. sales of approximately $606.2 million for the 12 months ending June 30, 2015. Read more...


U.S. Aims to Cut HIV Infections in Young Women in Africa

September 29, 2015 7:30 am | by Julie Pace, AP White House Correspondent | News | Comments

The Obama administration is announcing a $300 million program to drastically reduce HIV infections in girls and young woman in 10 sub-Saharan African nations hard hit by the virus. Read more...


Differences Found Between Smokers, Non-Smokers Who Develop Lung Cancer

September 29, 2015 7:15 am | by European Lung Foundation | News | Comments

Tobacco smoke is known to be the main risk factor for non-small cell lung cancer (NSCLC), although non-smokers can get it too. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.